IRCT20190428043404N2尚未招募2 期
Evaluation of Clemastine effects on clinical and electrodiagnostic parameters in Carpal tunnel syndrome (CTS) patients: A double blind RCT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 60 years（—）
- 性别
- All
入选标准
- •Pain or paresthesia or hypoesthesia in distal hand region or thenar weakness, with positive tinel or phalen tests
- •No clinical evidence of cervical radiculopathy or radicular pain
- •Negative history for Carpal Tunnel Release (CTR) surgery
- •No injection inside or in proximity of carpal tunnel in last 3 months
- •No present contraindication for Clemastine, such as drug allergy to antihistamine group
- •Patient is willing to knowingly participate in a clinical trial
排除标准
- •Patient isn't cooperative for questionnaire completion
- •Drug or alcohol addiction
- •Major depressive disorder or uncontrolled psychiatric disorders
- •Positive history for malignancy or infection in wrist or hand region
- •History of ischemic or neurovascular injury in wrist or hand region
- •Usage of other treatment measures during trial period
- •Patient doesn't follow correct treatment plan regarding drug or splint usage
研究者
相似试验
已完成
3 期
Evaluation of Therapeutic and safety of clemastine fumarate in symptoms and quality of life in secondry Relapsing MS patientsMultiple sclerosisMultiple sclerosis.IRCT20080901001165N40Bagheiat-allah University of Medical Sciences120
已完成
2 期
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingNCT02040298University of California, San Francisco50
招募中
2 期
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)Optic NeuritisNCT02521311University of California, San Francisco90
进行中（未招募）
1 期
Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosisCTIS2024-513099-17-00Amsterdam UMC Stichting80
招募中
3 期
Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosisMultiple sclerosis (MS)internuclear ophthalmoparesis (eye movement disorder)1003006110012303NL-OMON52129Amsterdam UMC80